2013
DOI: 10.1021/cn400182z
|View full text |Cite
|
Sign up to set email alerts
|

Dendrimer Advances for the Central Nervous System Delivery of Therapeutics

Abstract: The effectiveness of noninvasive treatment for central nervous system (CNS) diseases is generally limited by the poor access of therapeutic agents into the CNS. Most CNS drugs cannot permeate into the brain parenchyma because of the blood-brain barrier (BBB), and overcoming this has become one of the most significant challenges in the development of CNS therapeutics. Rapid advances in nanotechnology have provided promising solutions to this challenge. This review discusses the latest applications of dendrimers… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
103
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 146 publications
(104 citation statements)
references
References 127 publications
(244 reference statements)
0
103
0
1
Order By: Relevance
“…PAMAM dendrimers bearing amines at the surface are appealing vectors because they not only possess inherent functions for gene delivery [26,27] but offer controlled nanoscale building blocks for construction of defined delivery systems with multifunctionality [28,29]. Although high generation polycaFolic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells tionic PAMAM dendrimers tend to be more efficient in gene delivery, their generation-dependent toxicity is more prominent and surface functionalization is needed to maintain cytocompatibility and buffering capacity.…”
mentioning
confidence: 99%
“…PAMAM dendrimers bearing amines at the surface are appealing vectors because they not only possess inherent functions for gene delivery [26,27] but offer controlled nanoscale building blocks for construction of defined delivery systems with multifunctionality [28,29]. Although high generation polycaFolic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells tionic PAMAM dendrimers tend to be more efficient in gene delivery, their generation-dependent toxicity is more prominent and surface functionalization is needed to maintain cytocompatibility and buffering capacity.…”
mentioning
confidence: 99%
“…The functionalization of PAMAMs (G4-G12 PAMAM) dramatically reduces diffusion in the CNS and dendrimer penetration in living neurons [48]. Moreover, the PEGylation of dendrimers results in improved biocompatibility, reduced immunogenicity, increased water solubility, prolonged half-life and increased protection against nuclease, thus protecting siRNA cargo from degradation [60].…”
Section: Dendrimersmentioning
confidence: 99%
“…In the last few years, although numerous drug delivery carriers that can transport AEDs to the brain have been developed, including polymeric nanoparticles [5], polymeric micelles [6], and dendrimers [7], few of these carriers have advanced based on the pathological characteristics of epileptic seizures. We previously designed electroresponsive hydrogel nanoparticles (ERHNP) based on the abnormal electrical activity characteristics of epileptic seizures, and further modified ERHNP with the brain-targeting angiopep-2 peptide (ANG), a ligand of the low-density lipoprotein receptor-related protein, to improve penetration of the BBB [8].…”
Section: Introductionmentioning
confidence: 99%